Saturday links: deliberate efforts
Tadas Viskanta
Abnormal Returns
1 day ago
3 MIN READ
China
- Chinese EVs would clean up in the U.S. (theverge.com)
- China banned concealed door handles on EVs. (caranddriver.com)
- Why Chinese EVs won’t take over the world. (high-capacity.com)
AVs
- Waymo raised $16 billion in capital to expand operations. (cnbc.com)
- What Uber ($UBER) can teach about the economics of AVs. (sherwood.news)
EVs
- Tesla ($TSLA) sales in Europe are plummeting. (msn.com)
- ICE vehicle sales in Norway have effectively ended. (electrek.co)
- What is an EREV, or ‘extended-range electric vehicle’? (cnbc.com)
Energy
- Trump has not put a halt to the renewable energy boom in the U.S. (semafor.com)
- How Base Power looks to transform the residential electricity market. (wsj.com)
- On the prospects for a geothermal energy boom. (pitchbook.com)
- How to create more energy from hydropower. (theguardian.com)
Environment
- Evidence that lead levels in the U.S. have fallen dramatically over time. (semafor.com)
- MAHA is winning as flouride bans spread. (axios.com)
- Visualizing a warmer globe. (zacklabe.com)
Animals
- Humans are making the oceans noisier for animals. (insideclimatenews.org)
- How supporting honeybees can displace other bee species. (msn.com)
Behavior
- Why babies giggle. (nytimes.com)
- Creativity requires moments of boredom. (twopct.com)
- Six insights from Colette Jane Fehr’s new book, “The Cost of Quiet: How to Have the Hard Conversations That Create Secure, Lasting Love.” (nextbigideaclub.com)
Vaccines
- There’s really only one way to beat back measles. (theatlantic.com)
- The CDC has effectively put a hold on mRNA vaccine trials. (wapo.st)
- New parents are now rejecting Vitamin K injections for their babies. (nytimes.com)
Health
- Longevity may be more heritable than previously thought. (eurekalert.org)
- What GLP-1 users need to understand about nutrition. (sciencedaily.com)
- Statin side effects are rarer than commonly thought. (semafor.com)
- The Give Kids a Chance Act has finally passed and is set to become law. (thebulwark.com)
- Ransomware attacks are bad for hospital patients. (marginalrevolution.com)
- Where the quest for male birth control stands. (statnews.com)
- Why kidney disease is bad for the heart. (scitechdaily.com)
Fitness
- The problem(s) with observational exercise studies. (sensible-med.com)
- Always choose the stairs. (msn.com)
Drugs
Food
- How restaurants are looking to serve customers for all three meals. (nytimes.com)
- Olive cultivation in Italy is older than previously thought. (theconversation.com)
- Stop blaming Doordash for being broke. (newsletter.mikekonczal.com)
Sports
- Countries can’t be trusted to drug test their own athletes. (nytimes.com)
- Must how much MLB teams lose when their local broadcasting deals go away. (awfulannouncing.com)
- The case for restricting heading the ball in soccer. (semafor.com)
- Sports video games have stagnated. (neilpaine.substack.com)
Children
- How to make school less miserable for adolescents. (unpublishablepapers.substack.com)
- On the benefits of letting your children fail. (theatlantic.com)
- Boys are behind in reading at every age. (nytimes.com)
College
- Texas A&M is ending its programs in women’s and gender studies. (npr.org)
- Republican states are pushing hard to limit speech at universities. (economist.com)
Earlier on Abnormal Returns
- What you missed in our Friday linkfest. (abnormalreturns.com)
- Podcast links: advice for living. (abnormalreturns.com)
- Don’t miss a thing! Sign up for our daily e-mail newsletter. (abnormalreturns.com)
Mixed media
Terms and Conditions
This content, which contains security-related opinions and/or information, is provided for informational purposes only and should not be relied upon in any manner as professional advice, or an endorsement of any practices, products or services. There can be no guarantees or assurances that the views expressed here will be applicable for any particular facts or circumstances, and should not be relied upon in any manner. You should consult your own advisers as to legal, business, tax, and other related matters concerning any investment.
The commentary in this “post” (including any related blog, podcasts, videos, and social media) reflects the personal opinions, viewpoints, and analyses of the Ritholtz Wealth Management employees providing such comments, and should not be regarded the views of Ritholtz Wealth Management LLC. or its respective affiliates or as a description of advisory services provided by Ritholtz Wealth Management or performance returns of any Ritholtz Wealth Management Investments client.
References to any securities or digital assets, or performance data, are for illustrative purposes only and do not constitute an investment recommendation or offer to provide investment advisory services. Charts and graphs provided within are for informational purposes solely and should not be relied upon when making any investment decision. Past performance is not indicative of future results. The content speaks only as of the date indicated. Any projections, estimates, forecasts, targets, prospects, and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others.
Please see disclosures here.
